Overall, the lack of a clear gain in structural genomic variants in Smc3/Bcl6 lymphomas suggests that the types of lesions induced by Smc3 deficiency in GC B-cells may not yield efficient trajectories for malignant transformation, although the reduced DNA damage sensing may lead to accumulation of mutations in AICDA off-target genes. This evidence concerns the gene BCL6 and lymphoma.